Regulation of rat pineal melatonin synthesis: effect of monoamine oxidase inhibition.
Inhibition of pineal monoamine oxidase (MAO) activity either by harmine or pargyline in adult male Sprague-Dawley rats housed in a 12 : 12 LD cycle resulted in increase pineal N-acetyltransferase (NAT) activity. Pineal MAO inhibition also increased pineal melatonin content, presumably as a result of the increased NAT activity. Conjunct treatment with propranolol, a beta-adrenergic receptor antagonist, nullified these effects, regardless of the MAO inhibitor (harmine, pargyline or both) used or the inhibitor dose given. MAO inhibition during continuous light resulted in increased NAT activity greater than that observed following MAO inhibition during a 12 : 12 LD cycle. On the other hand, the increase in melatonin content following MAO inhibition during continuous light was not significantly different from that following MAO inhibition during a 12 : 12 LD cycle. Conjunct propranolol administration negated the effects of MAO inhibition on both the level of NAT activity and melatonin content, regardless of the lighting conditions. The level of pineal NAT activity is apparently regulated by the level of pineal beta-adrenergic receptor stimulation. While melatonin production appears to be dependent on increases in NAT activity, biosynthesis of this methoxyindole may also be regulated, in part, by other factors or processes in metabolic pathway.
D000123:Acetyltransferases / Q000032:analysis; D000818:Animals; D002940:Circadian Rhythm; D008297:Male; D008550:Melatonin / Q000096:biosynthesis*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010870:Pineal Gland / Q000187:drug effects / Q000378:metabolism*; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011943:Receptors, Adrenergic, beta / Q000187:drug effects
D008996:Monoamine Oxidase Inhibitors; D011943:Receptors, Adrenergic, beta; D011433:Propranolol; D000123:Acetyltransferases; D008550:Melatonin